US Patent Issued to The University of British Columbia, ProMIS Neurosciences on Feb. 24 for "Antibodies to misfolded TDP-43 and methods of use" (Canadian, American Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,548, issued on Feb. 24, was assigned to The University of British Columbia (Vancouver, Canada) and ProMIS Neurosciences Inc. (Toronto).

"Antibodies to misfolded TDP-43 and methods of use" was invented by Neil R. Cashman (Vancouver, Canada) and Johanne Kaplan (Sherborn, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure pertains to antibodies that specifically bind W68 in the context of DAGWGNL (SEQ ID NO: 1). Also provided are isolated peptides, isolated nucleic acids, immunogens, compositions, kits, and methods of using said reganents to detect misfolded TDP-43."

The patent was filed on Dec. 16, 2019, under Application No. 17/413,...